DCs effectively engulfed apoptotic tumour materials and exhibit enhanced tumour-associated antigens cross-presentation ability to naïve CD8+ T-cells, due to the IFN-enriched microenvironment that upregulate surface expression of major histocompatibility complex (MHC) class I molecules [51]. This evidence concerns the gene HLA-C and neoplasm.